L553-1147 Screening compound: ethyl 3-{3-[3-methyl-4-(piperidin-1-yl)-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]propanamido}benzoate

L553-1147 Screening compound: ethyl 3-{3-[3-methyl-4-(piperidin-1-yl)-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]propanamido}benzoate
L553-1147 Screening compound: ethyl 3-{3-[3-methyl-4-(piperidin-1-yl)-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]propanamido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L553-1147
ethyl 3-{3-[3-methyl-4-(piperidin-1-yl)-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]propanamido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L553-1147

Molecular Formula

C23H27N5O4 (C23 H27 N5 O4)

Compound Name

ethyl 3-{3-[3-methyl-4-(piperidin-1-yl)-[1,2]oxazolo[5,4-d]pyrimidin-6-yl]propanamido}benzoate

IUPAC name

ethyl 3-{3-[3-methyl-4-(piperidin-1-yl)-[12]oxazolo[54-d]pyrimidin-6-yl]propanamido}benzoate

SMILES

CCOC(c1cc(NC(CCc2nc(N3CCCCC3)c(c(C)no3)c3n2)=O)ccc1)=O

InChI

InChI=1S/C23H27N5O4/c1-3-31-23(30)16-8-7-9-17(14-16)24-19(29)11-10-18-25-21(28-12-5-4-6-13-28)20-15(2)27-32-22(20)26-18/h7-9,14H,3-6,10-13H2,1-2H3,(H,24,29)

InChI Key

ANRNHABXLVWGME-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27461282

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.5

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.315

Distribution Coefficient, logD

4.315

Water Solubility, LogSw

-4.45

Polar Surface Area

88.996

Acid Dissociation Constant (pKa)

11.81

Base Dissociation Constant (pKb)

3.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

L553-1147 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L553-1147 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L553-1147?
Check Price and Availability of L553-1147, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L553-1147 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L553-1147
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L553-1147
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L553-1147 available by request